TNBC - Triple-Negative Breast Cancer trials recruiting in California

All TNBC - Triple-Negative Breast Cancer trials nationally

Cities in California

Recruiting trials in California

• A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
  NCT06568692 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles, Oxnard
• Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
  NCT07211178 · Phase: Not specified · Ages: 18 Years to 99 Years · Sex: All (male and female) · California: Whittier
• I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
  NCT01042379 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Davis, Duarte, La Jolla, Los Angeles
• Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer
  NCT07017673 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles, Pasadena, Torrance
• Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation
  NCT05491226 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · California: Los Angeles